reason report
rais pt march investor meet ceo
bottom line increas convict op
march investor meet ceo joseph zubretski
director ir ryan kubota rais pt
margin turnaround well underway across clinic organiz
risk manag initi meaning margin upsid exist
ep bull case across conserv guidanc workforc
save tax reform addit base medicaid busi
turnaround make attract invest bull case ep
bp margin upsid margin could reach
bull case compar normal guidanc
top-lin growth potenti exist even re-up presenc
exchang marketplac despit new state medicaid contract
offer decid return growth contract mi
oh wi across dual ltss wa rfp reprocur
revenu like meaning posit catalyst submiss
april award may handicap probabl success
reprocur tx contract award oct balanc
sheet good view mm parent cash margin
turnaround limit need equiti rais may also bring like
posit beat i-day may
margin turnaround well underway substanti ep upsid
see near-term normal margin guidanc conserv
fact expect could much bp upsid net
margin guidanc carry-through
higher baselin bull case ep
estim compar consensu ep expect
margin upsid bp upsid consensu ep
ep ceo disagr
view current net margin guidanc could
even possibl driver turnaround play
multipl upsid driver margin turnaround addit base
medicaid busi turnaround workforc reduct complet
pbm specialti rx save even advanc op
contract expiri end unprofit exchang exit
rate increas reflect conserv guidanc tax reform
guid conserv compar peer mp even
wcg op addit potenti right-siz corpor
center loss fl nm contract exhibit
normal ep
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth compound-annual-growth-rate
compani inform leerink partner llc research
revenu billion ep estim ep quarterli number may sum annual total due round
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
wa reprocur pois posit catalyst may
impress wa contract repres revenu
annual revenu like success state
allow incumb appli largest incumb
market share region alreadi success
rfp due april award may link analysi
wa rfp link exhibit
tx downsid less fear discuss
ceo independ channel check handicap probabl
success reprocur tx contract repres
 revenu across region total see
network provid member relationship solid
presenc skill nurs facil offer greater likelihood
success hidalgo contract re-procur success potenti
posit read-across exhibit
organiz turnaround continu support margin
normal multipl effort align organ support
margin turnaround well underway posit held
terri bayer recent retir elimin favor
flat organ pam sedmak recent hire evp health
oper respons state health plan
report ceo zubretski plan retain account
individu head report pam sedmak similar structur
within legaci cvh cfo support effort margin turnaround
situat local market level exhibit
manag mechan also place act inform
receiv weekli dashboard cover pharmaci claim data
prior author lead indic medic cost
exchang potenti growth driver soon
impress exchang potenti growth driver
rate file due april though final decis due septemb
-- given observ improv margin stabil
industri revis price point exhibit
balanc sheet solid view oper turnaround limit
need capit rais exhibit
rais pt contempl price-to-earnings
normal ep price-to-earnings bull
case ep exhibit
increas convict march investor meet ceo
joseph zubretski director ir ryan kubota rais pt
meet offer import color on-going margin turnaround well state
manag medicaid re-procur tx wa well recent contract loss state
fl nm obtain color well prognosi growth includ possibl return
exchang well futur state medicaid growth opportun beyond
final obtain comfort balanc sheet capit posit liquid fund current
fewer growth effort encourag hear margin turnaround well underway
across clinic organiz risk manag initi margin guidanc
 clearli conserv particularli light tax reform meaning upsid
potenti least bp estim bull case ep consensu
guidanc mid-point workforc reduct complet pbm
margin even exist contract exchang exit addit margin tailwind
conserv contempl guidanc
bull case ep bp margin upsid see success
execut could drive net margin much bull case compar
normal guidanc offer bull case ep
top-lin growth potenti exist even earli re-up presenc
obamacar exchang marketplac despit new rfp submiss nc ky
compani plan particip offer decid return growth
contract mi oh wi across dual ltss multipl posit catalyst offer risk-
reward skew upsid
wa rfp re-procur revenu like meaning posit catalyst
submiss april award may handicap probabl success re-
procur all-import tx contract award octob see downsid
risk loss much lower fl nm contract loss given strong state relationship
leading-edg network contract skill nurs facil
balanc sheet good view mm parent cash oper turnaround
limit need immedi equiti rais long oper margin turnaround
smooth pt contempl price-to-earnings normal ep
price-to-earnings bull case ep may also bring like posit earn
beat i-day may
pleasur host investor meet ceo joseph zubretski
director ir ryan kubota march
meet offer import time color growth margin turnaround effort
well underway new leadership
see near-term normal margin guidanc conserv substanti
bull case
base bull case ep estim
fact expect could much bp upsid net margin
guidanc carry-through higher baselin base
case ep alreadi consensu see bull case ep
quit possibl like offer potenti beat rais
expect substanti beat come later year
driver base bull case ep
baselin ep ex one busi bp improv medicaid busi current flat guidanc premium revenueexchang margin pre-tax margin premium revenu mm guid savingstax reform tailwind tax reformrevenu premium revenu adjust pre-tax margin cost wage start-up mm addit comp start-up costsleeink base margin improv exchang bp addit margin improv exchang busi total pre-tax margin improv busi medicaid medicar improv addit bp total improv bp current flat guidanceleerink bull scenario inc
run-rat ep meaning higher report estim exclud one-tim
initi guidanc conserv room meaning upsid base case
ep midpoint adjust ep guidanc
consensu
report pre-tax break-up risk incom exclud exclud baselin ep ex- one ep exclud one-tim inc
ep guidanc conserv view leav room meaning upsid
parametercompani guidanc estimatesconsensu estimatespremium revenu fee reimburs tax revenu revenu incom revenu cost cost expens tax expens insur fee amort interest expens tax tax incom net incom share outstand guidanc inc
workforc reduct gener run-rat pre-tax save mm
much bp net margin expans
view guid margin conserv light fact
work forc reduct offer run-rat margin expans bp
ceo still see addit potenti right-siz corpor center loss fl
nm contract revenu combin
right-siz organ driver margin recoveri
compani restructur gener save mm
overal gener mm mm annual save
peopl workforc came reduc number manageri layer increas averag span control compani result million compens cost save half end medic cost line half end sg line along item produc million run rate save measur end manifest plan joseph zubretski presid ceo director inc earn inc
clinic initi offer meaning margin improv given compani
guid mission-driven mind-set even basic manag tool
techniqu employ
block tackl standard manag manag util prior
author concurr review elimin high cost provid network
specialist referr coordin care plan high risk member silver
bullet ceo make stride steer away mission-ori cultur
driven under-perform manag medic cost mlr
clinic initi also drive margin improv result start reflect sinc
exit unprofit exchang marketplac reduc membership
revenu member revenu
given substanti premium rate increas estim exchang
low singl digit posit neg pre-tax margin offer anoth bp
compani exit unprofit hix market significantli increas premium
specif implement premium increas averag effect januari premium increas includ increas absenc feder fund csr subsidi increas medic cost trend anti-select risk demograph varieti rate factor price increas along market exit utah wisconsin result substanti lower membership respons marketplac challeng increas premium rate significantli elimin exposur uncertainti around csr fund reconcili price full expect would reduc overal membership joseph zubretski presid ceo director inc earn inc
estim measur drive margin improv bp
pharmaci particularli specialti pharmaci offer under-appreci opportun
margin improv unit cost util superior formulari
manag addit potenti save also possibl start jan
renew pbm contract
total pharmaci spend much mm incur specialti
rx wcg effect abl drive consider margin improv area
meaning driver margin stori
estim hix membership revenu revenu actual/estim exposur pre-tax margin hix estimated/ guid pre-tax incom incom impact margin impact earn exposur exchang molina healthcar inc
after-tax margin guidanc tax reform tailwind clearli conserv guid
tailwind compar bp wcg gener
conserv bp net margin
ceo view realist outlook state rate negoti easili place
headwind time potenti bp tax tailwind chosen conserv
regard will held account higher after-tax margin
wcg abl sustain tailwind afford tax reform
risk manag mechan also place act inform receiv
weekli dashboard cover pharmaci claim data prior author
lead indic medic cost expans within hix marketplac offer potenti growth
driver
risk manag process place offer downsid protect
obvious risk adjust score import believ strongli risk adjust score lag acuiti popul pay risk adjust end higher acuiti popul doubl dip correct chart chase code put right protocol place make sure good competit qualiti score make sure risk adjust appropri underpay creat incred amount anxieti provid overpay lost money program place correct add signific valu well fraud wast abus unit anoth exampl basic meet complianc standard state contract produc return invest use see manag care compani lastli platform fragment dispar lot incred complex workaround conform mani instanc uniform platform health plan believ strongli form outsourc co-sourc relationship major vendor futur help us implement drive execut core technolog need order viabl health plan joseph zubretski presid ceo director inc earn inc
compani focus area claim manag would offer downsid protect
streamlin platform risk manag process
multipl effort align organ support margin turnaround well
posit previous held terri bayer recent retir elimin
favor flatter organ
pam sedmak recent hire evp health oper respons
state health plan report ceo zubretski plan retain account
individu head report pam sedmak similar structur within legaci cvh cfo
support effort margin turnaround situat local market level
biggest chang corpor center streamlin drive
effect support local health plan recruit current underway head
clinic servic ceo assert effort alreadi reinvigor critic
 respons
impress wa contract repres revenu
annual revenu like success
state allow incumb appli largest incumb
market share region alreadi success propos due
april award may
link wa rfp analysi wa medicaid rfp analysi re-procur risk limit
would also like announc hire pam sedmak execut vice presid health oper pam respons health plan oper turn around underperform solidifi reprocur effort execut margin recoveri sustain plan across fundament manag care joseph zubretski presid ceo director inc con call inc
wa reprocur could posit catalyst may contract repres
market leader wa includ alreadi reprocur region
estim beneficiari market shareestim revenu exposur mm healthplan inc
discuss ceo independ channel check handicap
probabl success reprocur
tx contract repres revenu across region total see
network provid member relationship solid presenc skill
nurs facil offer greater likelihood success
would remind rate part either one propos capabl servic profil rate negoti later phenomenon new player come tri sort invest state exist either one washington market share great platform integr behavior medic track record two nine region alreadi two nine region washington actual went procur past two year actual grew membership re-procur cost base washington run value-bas contract believ best market feel pretti good market share perspect abil grow servic profil track record either state joseph zubretski presid ceo director inc con call inc
present region tx
 exposur tx reprocur
fl qualiti score weak though like impact hix growth howev detail
score specif fl rfp still publicli disclos though broader score
avail kaiser ncqa
june
impress exchang potenti growth driver rate file
due april though final decis due septemb given observ
improv margin stabil industri revis price
exchang could potenti growth driver
respect marketplac earli strateg view need themarketplac medicaid vice versa think market learn aresimilar network configur cost two busi quit independ realli warm transfer member two market go exchang go exchang view busi produc target margin cash flow fit portfolio stand marketplac busi texa incred profit florida problem five market target still profit go file rate april go see profit emerg year make final call august septemb need pretti confid rate increas pre-tax target margin could sustain busi enterpris joseph zubretski presid ceo director inc earn inc
top-lin ep sensit hix membership growth
balanc sheet continu improv debt capit parent cash
hix membership growth upsid mm consensu revenu incom impact ep inc
compani end debt cap
continu oper turnaround help delev balanc sheet
capitaland reason pop leverag actual reduct equiti due charg took joseph zubretski presid ceo director inc call think best way express view leverag realli light expect abl make better inform decis see profit improv driven everyth talk today manifest earn basic go go manag cash leverag appropri go bring much disciplin go focus manag far major decis go forward go first see much grow way lower debt-tocap ratio retain earn joseph white cfo inc call inc
increas guid dilut share count due convert debt
mind let share follow assumpt underli preliminari guidanc first preliminari guidanc assum dilut weight averag share count million share base share price per share share count may higher expect primarili result dilut natur convert debt higher share price regardless assumpt make around dilut impact convert note pleas rememb issu million share part exchang equiti million face valu convert note last decemb addit million share includ share count regardless assumpt may make around dilut cost convert debt joseph white cfo inc earn call inc
trade price-to-earnings conserv base case ep
except per oper tax contract oper incom continu net incom net ep ex-on growth inc
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
multipl expans use absolut rel price-to-earnings multipl base approach valuat
ep estim combin price-to-earnings base approach dcf model point
intrins valu compani plu add premium deal probabl
price target repres price-to-earnings ep
downsid risk invest thesi valuat aet legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn
upsid risk invest thesi valuat aet accret acquisit
aggress share repurchas use solid parent cash posit debt rais
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
new pt contempl price-to-earnings ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
base price-to-earnings multipl appli stand-alone ep rate ci
outperform price target
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price base case
ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
remain posit reiter op rate month pt
contempl price-to-earnings ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost
trend util improv economi
pt reflect price-to-earnings averag ep
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
